Account Ginsenoside Rg1
- Catalog No. :
- ACSETO083
- CAS No. :
- 22427-39-0
- Molecular Formula :
- C42H72O14
- Molecular Weight :
- 801.02
IUPAC Name:(2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$130.00Login to see priceIn stockInquiry
5g98%$446.00Login to see priceIn stockInquiry
25g98%$1713.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | Ginsenoside Rg1 |
|---|---|
| IUPAC Name | (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| MDL No. | MFCD00210293 |
| Molecular Formula | C42H72O14 |
| Molecular Weight | 801.02 |
| SMILES | C[C@@]12[C@@]([H])([C@](C)([C@]3([C@H](C2)O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)[H])CC[C@@H](C3(C)C)O)C[C@H]([C@]5([C@]1(CC[C@@H]5[C@@](C)(O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)CO)CC/C=C(C)\C)C)[H])O |
| InChI Key | YURJSTAIMNSZAE-HHNZYBFYSA-N |
| Synonym | (3b,6a,12b)-3,12-dihydroxydammar-24-ene-6,20- diylbis(beta-d-glucopyranoside) | CCG-270492 | Panaxoside A | EX-A6784 | (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20- DIYLBIS(.BETA.-D-GLUCOPYRANOSIDE) | Q-100285 | EINECS 244-989-9 | A816192 |
| CAS No. | 22427-39-0 |
| PubChem CID | 441923 |
Synthetic Route by SureRoute
2. ACSETO083 Molecular Building Block Synthetic Route
(2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(((S)-6-methyl-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)hept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol
(2R,3R,4S,5S,6R)-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-Hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol